Combining a tyrosine kinase inhibitor (imatinib) and a thiazolidinedione (pioglitazone) is proposed for the treatment of chronic myeloid leukemia.
N. Engl. J. Med. 2015 Nov 12;373(20):1973-5.
Abstract Combining a tyrosine kinase inhibitor (imatinib) and a thiazolidinedione (pioglitazone) is proposed for the treatment of chronic myeloid leukemia.
You can also include formatting, links, images and footnotes in your notes
Simple formatting can be added to notes, such as *italics*, _underline_ or **bold**.
Superscript can be denoted by <sup>text</sup> and subscript <sub>text</sub>.
Numbered or bulleted lists can be created using either numbered lines 1. 2. 3., hyphens - or asterisks *.
Links can be included with: [my link to pubmed](http://pubmed.com)
Images can be included with: 
For footnotes use [^1](This is a footnote.) inline.
Or use an inline reference [^1] to refer to a longer footnote elseweher in the document [^1]: This is a long footnote..